AI-generated summary
The authors prospectively studied a new frequency-doubled nanosecond-pulsed laser (2RT) in a pilot series of 23 patients with newly diagnosed diabetic macular edema, with 17 patients completing six months of follow-up. They report no complications, a statistically significant improvement in visual acuity, and reductions in central macular thickness and leakage in most patients, though the thickness change was not statistically significant. The authors note that comparison with standard laser treatment requires further study.
- Participants
- 17
- Who or what was studied
- Patients with newly diagnosed diabetic macular edema
- Limits stated in the abstract
- The abstract describes a small pilot study with no comparison group, and the central macular thickness change was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study, Retina, Photoreceptor. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.